CA2206754A1 - Benzimidazole derivatives with antihistaminic activity - Google Patents

Benzimidazole derivatives with antihistaminic activity

Info

Publication number
CA2206754A1
CA2206754A1 CA002206754A CA2206754A CA2206754A1 CA 2206754 A1 CA2206754 A1 CA 2206754A1 CA 002206754 A CA002206754 A CA 002206754A CA 2206754 A CA2206754 A CA 2206754A CA 2206754 A1 CA2206754 A1 CA 2206754A1
Authority
CA
Canada
Prior art keywords
benzimidazole derivatives
ethyl
methyl
short chain
antihistaminic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002206754A
Other languages
French (fr)
Other versions
CA2206754C (en
Inventor
Aurelio Orjales
Victor Rubio
Maravillas Bordell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Publication of CA2206754A1 publication Critical patent/CA2206754A1/en
Application granted granted Critical
Publication of CA2206754C publication Critical patent/CA2206754C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

New benzimidazole derivatives of formula: (see formula I) in which R1 is H or a short chain hydrocarbon group such as methyl, ethyl, isopropyl, cyclopropyl, vinyl, etc., and R2 is a group selected from among the following: CH2OH, COOH, COOR3 and 4,4- dimethyl-2-oxazolinyl, R3 being a short chain alkyl group such as methyl, ethyl, etc., are described. A description is also made of the preparation of these compounds, which have a high H1 antihistaminic and antiallergic activity and are devoid of effects on the central nervous and cardiovascular systems.
CA002206754A 1996-06-04 1997-06-03 Benzimidazole derivatives with antihistaminic activity Expired - Lifetime CA2206754C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP9601236 1996-06-04
ES09601236A ES2124167B1 (en) 1996-06-04 1996-06-04 NEW DERIVATIVES OF BENZMIDAZOLE WITH ANTIHISTAMINE ACTIVITY.

Publications (2)

Publication Number Publication Date
CA2206754A1 true CA2206754A1 (en) 1997-12-04
CA2206754C CA2206754C (en) 2007-01-23

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002206754A Expired - Lifetime CA2206754C (en) 1996-06-04 1997-06-03 Benzimidazole derivatives with antihistaminic activity

Country Status (27)

Country Link
US (1) US5877187A (en)
EP (1) EP0818454B1 (en)
JP (1) JP4218991B2 (en)
CN (1) CN1105716C (en)
AR (1) AR008386A1 (en)
AT (1) ATE264317T1 (en)
AU (1) AU725700B2 (en)
BR (1) BR9703276A (en)
CA (1) CA2206754C (en)
CZ (1) CZ289278B6 (en)
DE (2) DE69728608T2 (en)
DK (1) DK0818454T3 (en)
ES (1) ES2124167B1 (en)
FR (1) FR11C0023I2 (en)
HR (1) HRP970307B1 (en)
HU (1) HU227598B1 (en)
IN (1) IN186319B (en)
LU (1) LU91798I2 (en)
MX (1) MXPA97004127A (en)
NO (2) NO313195B1 (en)
PL (1) PL188908B1 (en)
PT (1) PT818454E (en)
RU (1) RU2182150C2 (en)
SI (1) SI0818454T1 (en)
TR (1) TR199700464A2 (en)
TW (1) TW438794B (en)
ZA (1) ZA974893B (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1092711A4 (en) 1998-07-01 2002-07-31 Takeda Chemical Industries Ltd Retinoid-associated receptor regulators
USRE39608E1 (en) 1998-11-27 2007-05-01 Abbott Gmbh & Co. Kg Substituted benzimidazoles and their use as PARP inhibitors
ES2151442B1 (en) * 1999-01-11 2001-07-01 Espanola Prod Quimicos NEW DERIVATIVE OF BENCENOETHANOL.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
ES2278018T3 (en) 2002-04-19 2007-08-01 Faes Farma, S.A. ACID POLYMORPH 4- (2- (4- (1- (2-ETOXIETIL) -1H-BENCIMIDAZOL-2-IL) -1-PIPERIDINIL) ETIL) -ALFA, ALPHA-DIMETHYL-BENCENOACETIC.
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101123903B1 (en) * 2008-02-12 2012-03-23 주식회사유한양행 Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds
JP2010013472A (en) * 2009-09-09 2010-01-21 Faes Farma Sa POLYMORPH OF 4-[2-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOL-2-YL]-1-PIPERIDINYL] ETHYL-alpha,alpha-DIMETHYL BENZENOACETIC ACID
CN102675101B (en) * 2012-05-16 2014-01-29 王蕾 Preparation method of 2-(4-haloethyl) phenyl-2-methyl propionic ester and synthesis method of bilastine
CZ307500B6 (en) 2012-08-15 2018-10-24 Zentiva, K.S. A method of the preparation of a 2-methyl-2'-phenylpropionic acid derivative employing novel intermediates
RU2671577C2 (en) * 2013-03-15 2018-11-02 Геркулес Ллк Composition and method of producing personal care compositions with improved deposition properties
CN103214454A (en) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 Bilastine crystal and preparation method thereof
CN103214455B (en) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 A kind of preparation method of bilastine
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (en) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 A method of preparing bilastine
CN104447683A (en) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 Stable Bilastine compound
CN103896915A (en) * 2014-04-01 2014-07-02 中国药科大学 Benzimidazole derivative and preparation method thereof as well as application of benzimidazole derivative in medicine
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (en) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 Preparation method of bilastine impurity
ES2600827B9 (en) * 2015-07-24 2018-03-28 Urquima, S.A CRYSTALLINE FORMS OF BILASTINE AND PROCEDURES FOR PREPARATION
CN105272977A (en) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 Bilastine intermediate preparation method
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
WO2017191651A1 (en) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
CN107365298A (en) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 A kind of preparation method of the benzyl propionate derivant of 2 methyl 2 '
CN109456316A (en) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 A kind of preparation method of bilastine impurity
EP3453384B1 (en) 2017-09-07 2020-05-27 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine
LT3681475T (en) 2017-10-16 2021-02-25 Faes Farma, S.A. Aqueous compositions comprising bilastine and mometasone
PL3641735T3 (en) 2017-12-18 2021-09-06 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler
EP3470062B1 (en) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate
PT3740191T (en) 2018-01-18 2021-07-09 Faes Farma Sa Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
CN109081827A (en) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 A kind of preparation method and application of bilastine
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
CR20230109A (en) 2020-07-30 2023-05-11 Faes Farma Sa Decongestant drug delivery system
CN112110893A (en) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 Preparation method of bilastine
JP2023549381A (en) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． Orodispersible powder compositions containing antihistamine active compounds
EP4267109A1 (en) 2020-12-23 2023-11-01 Noucor Health S.A. A non-micronized bilastine composition
WO2023156559A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (en) * 1992-07-20 1994-12-16 Espanola Prod Quimicos PROCEDURE FOR THE PREPARATION OF NEW PIPERIDIC DERIVATIVES OF BENCIMIDAZOLE.
DE69334145T2 (en) * 1992-08-03 2008-01-24 Sepracor Inc., Marlborough Terfenadine carboxylate and the treatment of skin irritation
WO1995000480A1 (en) * 1993-06-25 1995-01-05 Merrell Pharmaceuticals Inc. Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives

Also Published As

Publication number Publication date
CN1105716C (en) 2003-04-16
ES2124167A1 (en) 1999-01-16
EP0818454A1 (en) 1998-01-14
TW438794B (en) 2001-06-07
NO2011008I2 (en) 2012-05-14
ES2124167B1 (en) 1999-09-16
RU2182150C2 (en) 2002-05-10
AU2467297A (en) 1997-12-11
TR199700464A3 (en) 1997-12-21
HUP9700997A1 (en) 1999-09-28
CA2206754C (en) 2007-01-23
AU725700B2 (en) 2000-10-19
CN1176964A (en) 1998-03-25
MXPA97004127A (en) 2005-07-25
ATE264317T1 (en) 2004-04-15
TR199700464A2 (en) 1997-12-21
DE69728608D1 (en) 2004-05-19
LU91798I2 (en) 2011-05-23
HU227598B1 (en) 2011-09-28
NO2011008I1 (en) 2011-06-06
ZA974893B (en) 1997-12-30
HU9700997D0 (en) 1997-07-28
FR11C0023I1 (en) 2011-08-19
PT818454E (en) 2004-08-31
NO972525L (en) 1997-12-05
NO313195B1 (en) 2002-08-26
PL188908B1 (en) 2005-05-31
HRP970307B1 (en) 2002-02-28
DE69728608T2 (en) 2005-04-21
PL320358A1 (en) 1997-12-08
FR11C0023I2 (en) 2012-03-16
BR9703276A (en) 2004-08-17
CZ172397A3 (en) 1997-12-17
EP0818454B1 (en) 2004-04-14
HRP970307A2 (en) 1998-04-30
CZ289278B6 (en) 2001-12-12
SI0818454T1 (en) 2004-08-31
DK0818454T3 (en) 2004-07-12
US5877187A (en) 1999-03-02
AR008386A1 (en) 2000-01-19
IN186319B (en) 2001-08-04
JPH1059961A (en) 1998-03-03
NO972525D0 (en) 1997-06-03
JP4218991B2 (en) 2009-02-04
DE122011000006I1 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
CA2206754A1 (en) Benzimidazole derivatives with antihistaminic activity
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
AU5374294A (en) 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
CA2165819A1 (en) Dc-89 derivatives
WO2001072728A3 (en) Novel piperazine derivatives
WO2001010842A3 (en) Melanocortin-4 receptor binding compounds and methods of use thereof
EP0513387A4 (en) Active oxygen inhibitor
CA2270964A1 (en) Benzonaphthyridines as bronchial therapeutics
CA2046874A1 (en) Derivatives of n-phenylbenzamide with anti-ulcer and anti-allergy activity and a method for their preparation
CA2094300A1 (en) Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
WO1999000373A8 (en) Benzimidazole derivatives
AU644051B2 (en) Piperidine derivatives
CA2154721A1 (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
WO2001062705A3 (en) Aminoalcohol derivatives
EP0640586A4 (en) Stilbene derivative and stilbene analog derivative, and use thereof.
CA2114727A1 (en) Quinoline Derivatives as Immunostimulants
CA2361614A1 (en) Compositions for treating inflammatory response
DE69413393T2 (en) 4-AZASTEROIDS SUBSTITUTED IN THE 15-POSITION
WO1997049703A3 (en) Oxazolone derivatives and their use as anti-helicobacter pylori agents
CA2120028A1 (en) Indol Derivatives for the Treatment of Migrane
ATE228364T1 (en) INDOLE ALKALOIDS AS ANTI-INFLAMMATORY ACTIVE INGREDIENTS
AU3626895A (en) Quinazolinone pharmaceuticals and use thereof
EP1142880A4 (en) Benzimidazole derivatives
IL137794A0 (en) Streptogramin derivatives, preparation method and compositions containing same
WO2001009122A3 (en) Serotonergic benzofurans

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170605